ReviewPediatric nephrology (Berlin, Germany)2009
Treatment-based literature of Henoch-Schönlein purpura nephritis in childhood.
Review in Pediatric nephrology (Berlin, Germany), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.
- Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to Henoch-Schönlein purpura: a meta-analysis.Journal of the renin-angiotensin-aldosterone system : JRAASPooled it
- Outcome of children with IgA vasculitis with nephritis treated with steroids: a matched controlled study.Pediatric nephrology (Berlin, Germany) · 2023Observational
- Leflunomide therapy for IgA vasculitis with nephritis in children.BMC pediatrics · 2021Article
- Management of IgA Vasculitis with Nephritis.Paediatric drugs · 2021Review
- Henoch-Schönlein Purpura Complicated by Hepatocellular Carcinoma.Internal medicine (Tokyo, Japan) · 2017Article
- Evaluation of Mycophenolate Mofetil and Low-Dose Steroid Combined Therapy in Moderately Severe Henoch-Schönlein Purpura Nephritis.Medical science monitor : international medical journal of experimental and clinical research · 2017Article
- Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature.Immunologic research · 2017Review
- Therapeutic advances in the treatment of vasculitis.Pediatric rheumatology online journal · 2016Review
- IgA vasculitis (formerly Henoch-Schönlein purpura) in an adult with systemic lupus erythematosus.BMJ case reports · 2015Article
- Atypical course of Henoch-Schonlein purpura in an adult patient.Reumatologia · 2015Article
- 24h Urinary Protein Levels and Urine Protein/Creatinine Ratios Could Probably Forecast the Pathological Classification of HSPN.PloS one · 2015Article
- Henoch-Schönlein purpura in children: limited benefit of corticosteroids.Canadian family physician Medecin de famille canadien · 2014Article
- Successful outcome of a corticodependent henoch-schönlein purpura adult with rituximab.Case reports in medicine · 2014Article
- Chapter 11: Henoch-Schönlein purpura nephritis.Kidney international supplements · 2012Article
- [Henoch-Schönlein purpura : most frequent form of vasculitis in childhood and adolescence].Zeitschrift fur Rheumatologie · 2011Article
- High prevalence of sinusitis in children with henoch-schönlein purpura.International journal of pediatrics · 2011Article
- The incidence and severity of Henoch-Schönlein purpura nephritis over a 22-year period in Fukushima Prefecture, Japan.International urology and nephrology · 2010Article
- Clinical practice: Diagnosis and management of Henoch-Schönlein purpura.European journal of pediatrics · 2010Review
- Small vessel vasculitis.Pediatric nephrology (Berlin, Germany) · 2010Review
- Henoch-schonlein purpura-a case report and review of the literature.Gastroenterology research and practice · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Considerable concern has been expressed on the importance of identifying an improved therapeutic protocol for use in the treatment of childhood Henoch-Schönlein purpura nephritis, primarily due to the unpredictable success shown to date in improving long-term renal outcome. This review focuses on published reports describing the outcomes of therapeutic approaches currently being used in the treatment of pediatric Henoch-Schönlein purpura nephritis, with the aim of providing information that will facilitate a treatment-based approach in children presenting with varying degrees of kidney disease. The conclusions of the authors of this review are that currently prescribed treatments of children affected by Henoch-Schönlein purpura nephritis are not adequately guided by evidence obtained in properly designed, randomized, placebo-controlled trials with outcome markers related to the progression to end stage renal disease (level I evidence). Moreover, firm evidence supporting the best practice to be applied with the aim of delaying the progression of kidney disease is still lacking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.